• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢腺癌毒力的组织学关联。II. 宿主反应的形态学关联。

Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response.

作者信息

Deligdisch L, Jacobs A J, Cohen C J

出版信息

Am J Obstet Gynecol. 1982 Dec 15;144(8):885-9. doi: 10.1016/0002-9378(82)90178-8.

DOI:10.1016/0002-9378(82)90178-8
PMID:6890770
Abstract

Original histologic slides were reviewed from 87 patients with advanced ovarian carcinoma, all of whom had been treated with cisplatin, alone or in combination. The degree of lymphocyte infiltration in the tumor was not related to histologic or cytologic tumor differentiation. However, the degree of lymphocyte infiltration was related to improved survival.

摘要

对87例晚期卵巢癌患者的原始组织学切片进行了回顾,所有患者均接受了顺铂单药或联合用药治疗。肿瘤中淋巴细胞浸润程度与组织学或细胞学肿瘤分化无关。然而,淋巴细胞浸润程度与生存期改善相关。

相似文献

1
Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response.卵巢腺癌毒力的组织学关联。II. 宿主反应的形态学关联。
Am J Obstet Gynecol. 1982 Dec 15;144(8):885-9. doi: 10.1016/0002-9378(82)90178-8.
2
Histologic correlates of virulence in ovarian adenocarcinoma. I. Effect of differentiation.卵巢腺癌毒力的组织学相关性。I. 分化的影响。
Am J Obstet Gynecol. 1982 Jul 1;143(5):574-80. doi: 10.1016/0002-9378(82)90550-6.
3
Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.在晚期卵巢腺癌患者接受基于顺铂的静脉化疗后,手术记录的腹腔内注射顺铂、阿糖胞苷和博来霉素的反应。
J Clin Oncol. 1988 Nov;6(11):1679-84. doi: 10.1200/JCO.1988.6.11.1679.
4
Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy.在接受以顺铂为基础的化疗的卵巢癌中,等位基因型作为潜在的预后标志物。
Int J Mol Med. 2003 May;11(5):621-5.
5
Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.放射疗法作为顺铂增敏剂在耐药卵巢癌细胞系中的应用
Cancer. 1996 May 1;77(9):1850-3. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1850::AID-CNCR14>3.0.CO;2-Z.
6
[Cytogenetic studies on ovarian cancer].[卵巢癌的细胞遗传学研究]
Krebsarzt. 1968;23(1):1-9.
7
Expression of NLK and its potential effect in ovarian cancer chemotherapy.NLK 的表达及其在卵巢癌化疗中的潜在作用。
Int J Gynecol Cancer. 2011 Nov;21(8):1380-7. doi: 10.1097/IGC.0b013e3182262030.
8
Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II study.表柔比星与不治疗作为晚期卵巢癌巩固治疗的比较:一项II期研究结果
Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:74-8. doi: 10.1111/j.1525-1438.2006.00313.x.
9
Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.卵巢癌患者肿瘤积液细胞中p53的表达与突变:对基于顺铂化疗的反应
Tumour Biol. 2001 Mar-Apr;22(2):83-91. doi: 10.1159/000050601.
10
[Treatments of epithelial ovarian cancer by histologic subtype].
Gan To Kagaku Ryoho. 2009 Feb;36(2):187-92.

引用本文的文献

1
Human Immunodeficiency Virus-Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers.人类免疫缺陷病毒与肺癌、乳腺癌和前列腺癌肿瘤免疫微环境差异的相关性
Cancer Epidemiol Biomarkers Prev. 2025 Jun 3;34(6):860-867. doi: 10.1158/1055-9965.EPI-24-1421.
2
The concept of immune surveillance against tumors. The first theories.针对肿瘤的免疫监视概念。最初的理论。
Oncotarget. 2017 Jan 24;8(4):7175-7180. doi: 10.18632/oncotarget.12739.
3
Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.
上皮性卵巢癌预后因素的最新进展
Int Sch Res Notices. 2014 Oct 29;2014:953509. doi: 10.1155/2014/953509. eCollection 2014.
4
Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies.肿瘤浸润淋巴细胞的免疫效应及其与卵巢恶性肿瘤患者生存率的关系。
J Tongji Med Univ. 1991;11(4):235-9. doi: 10.1007/BF02888158.